Newsroom
08 October 2015
SUDA Allowed First USA Patent for SUD-003 and SUD-004
8th October 2015, ASX Announcement SUDA has been allowed its first patent in the USA for “Oral Spray Formulations and Methods for Administration of Sildenafil” for the treatment of SSRI-induced…
